• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Protective trend of anti-androgen therapy during the COVID-19 pandemic: A meta-analysis.

作者信息

Meng Jialin, Ge Qintao, Li Jiawei, Lu Xiaofan, Chen Yonghao, Wang Haitao, Zhang Meng, Du Juan, Zhang Li, Hao Zongyao, Liang Chaozhao

机构信息

Department of Urology, The First Affiliated Hospital of Anhui Medical University, Institute of Urology, Anhui Medical University, Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, 218th Jixi Road, Hefei, Anhui 230022, China.

State Key Laboratory of Natural Medicines, Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing 211198, China; Department of Cancer and Functional Genomics, Institute of Genetics and Molecular and Cellular Biology, CNRS/INSERM/UNISTRA, Illkirch 67400, France.

出版信息

J Infect. 2022 Jun;84(6):834-872. doi: 10.1016/j.jinf.2022.03.020. Epub 2022 Mar 24.

DOI:10.1016/j.jinf.2022.03.020
PMID:35341831
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8944116/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e17d/8944116/091ee0a9c5a7/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e17d/8944116/0179e87269db/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e17d/8944116/091ee0a9c5a7/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e17d/8944116/0179e87269db/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e17d/8944116/091ee0a9c5a7/gr2_lrg.jpg

相似文献

1
Protective trend of anti-androgen therapy during the COVID-19 pandemic: A meta-analysis.COVID-19大流行期间抗雄激素治疗的保护趋势：一项荟萃分析。
J Infect. 2022 Jun;84(6):834-872. doi: 10.1016/j.jinf.2022.03.020. Epub 2022 Mar 24.
2
Immune response and potential therapeutic strategies for the SARS-CoV-2 associated with the COVID-19 pandemic.与 COVID-19 大流行相关的 SARS-CoV-2 的免疫反应和潜在治疗策略。
Int J Biol Sci. 2022 Feb 14;18(5):1865-1877. doi: 10.7150/ijbs.66369. eCollection 2022.
3
COVID-19 Pandemic and Infant Neurodevelopmental Impairment: A Systematic Review and Meta-analysis.COVID-19 大流行与婴儿神经发育障碍：系统评价和荟萃分析。
JAMA Netw Open. 2022 Oct 3;5(10):e2238941. doi: 10.1001/jamanetworkopen.2022.38941.
4
Surveillance Metrics of SARS-CoV-2 Transmission in Central Asia: Longitudinal Trend Analysis.中亚地区 SARS-CoV-2 传播的监测指标：纵向趋势分析。
J Med Internet Res. 2021 Feb 3;23(2):e25799. doi: 10.2196/25799.
5
Impacts of COVID-19 and SARS-CoV-2 on male reproductive function: a systematic review and meta-analysis protocol.COVID-19 和 SARS-CoV-2 对男性生殖功能的影响：系统评价和荟萃分析方案。
BMJ Open. 2022 Jan 5;12(1):e053051. doi: 10.1136/bmjopen-2021-053051.
6
Systematic reviews and meta-analyses during the SARS-CoV-2 pandemic.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）大流行期间的系统评价和荟萃分析。
Einstein (Sao Paulo). 2022 Jun 24;20:eCE0041. doi: 10.31744/einstein_journal/2022CE0041. eCollection 2022.
7
SARS-CoV-2: The Monster Causes COVID-19.严重急性呼吸综合征冠状病毒 2：引发 COVID-19 的元凶。
Front Cell Infect Microbiol. 2022 Feb 8;12:835750. doi: 10.3389/fcimb.2022.835750. eCollection 2022.
8
Androgen deprivation therapy and excess mortality in men with prostate cancer during the initial phase of the COVID-19 pandemic.雄激素剥夺疗法与 COVID-19 大流行初始阶段男性前列腺癌患者的超额死亡率。
PLoS One. 2021 Oct 7;16(10):e0255966. doi: 10.1371/journal.pone.0255966. eCollection 2021.
9
Prevalence of SARS-CoV-2 antibodies in pediatric healthcare workers.儿科医护人员中新冠病毒抗体的流行情况。
Int J Infect Dis. 2021 Apr;105:474-481. doi: 10.1016/j.ijid.2021.03.017. Epub 2021 Mar 12.
10
Medicine shortages in the hospital setting: analysis of the trend in five Italian centres during the three waves of the SARS-CoV-2 pandemic.医院环境中的药品短缺：对意大利五个中心在SARS-CoV-2大流行三波期间趋势的分析。
Eur J Hosp Pharm. 2023 Jan;30(1):e6. doi: 10.1136/ejhpharm-2021-003066. Epub 2021 Oct 18.

引用本文的文献

1
Assessment of Postvaccination Neutralizing Antibodies Response against SARS-CoV-2 in Cancer Patients under Treatment with Targeted Agents.接受靶向药物治疗的癌症患者接种疫苗后针对严重急性呼吸综合征冠状病毒2的中和抗体反应评估
Vaccines (Basel). 2022 Sep 5;10(9):1474. doi: 10.3390/vaccines10091474.
2
COVID-19 Severity and Androgen Receptor Polymorphism.新型冠状病毒肺炎严重程度与雄激素受体多态性
Biology (Basel). 2022 Jun 28;11(7):974. doi: 10.3390/biology11070974.

本文引用的文献

1
A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data.抗雄激素治疗对 COVID-19 结局影响的 2 期临床试验：无获益证据，流行病学和体外数据支持。
Eur Urol. 2022 Mar;81(3):285-293. doi: 10.1016/j.eururo.2021.12.013. Epub 2021 Dec 15.
2
5α-Reductase Inhibitors Are Associated with Reduced Risk of SARS-CoV-2 Infection: A Matched-Pair, Registry-Based Analysis.5α-还原酶抑制剂与降低 SARS-CoV-2 感染风险相关：一项匹配对、基于登记的分析。
J Urol. 2022 Jan;207(1):183-189. doi: 10.1097/JU.0000000000002180. Epub 2021 Aug 26.
3
The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells.
雄激素拮抗剂恩扎卢胺下调 TMPRSS2，减少 SARS-CoV-2 在人肺细胞中的细胞进入。
Nat Commun. 2021 Jul 1;12(1):4068. doi: 10.1038/s41467-021-24342-y.
4
Targeting androgen regulation of TMPRSS2 and ACE2 as a therapeutic strategy to combat COVID-19.将雄激素对TMPRSS2和ACE2的调控作为对抗COVID-19的治疗策略。
iScience. 2021 Mar 19;24(3):102254. doi: 10.1016/j.isci.2021.102254. Epub 2021 Mar 1.
5
Targeting transcriptional regulation of SARS-CoV-2 entry factors and .靶向严重急性呼吸综合征冠状病毒2（SARS-CoV-2）进入因子的转录调控及…… （原文此处不完整）
Proc Natl Acad Sci U S A. 2021 Jan 5;118(1):e2021450118. doi: 10.1073/pnas.2021450118. Epub 2020 Dec 28.
6
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532).雄激素剥夺疗法治疗前列腺癌与 SARS-CoV-2 感染风险的关系：一项基于人群的研究（N=4532）。
Ann Oncol. 2020 Aug;31(8):1040-1045. doi: 10.1016/j.annonc.2020.04.479. Epub 2020 May 6.
7
Topical Antiandrogen Therapies for Androgenetic Alopecia and Acne Vulgaris.局部用抗雄激素疗法治疗雄激素性脱发和寻常痤疮。
Am J Clin Dermatol. 2020 Apr;21(2):245-254. doi: 10.1007/s40257-019-00493-z.
8
Androgen receptor-related diseases: what do we know?雄激素受体相关疾病：我们了解什么？
Andrology. 2016 May;4(3):366-81. doi: 10.1111/andr.12167. Epub 2016 Mar 16.